Gabreal Pharmaceuticals Pvt Ltd - Charges

Every charge - open or closed - that lenders have registered against Gabreal Pharmaceuticals Pvt Ltd, with the most recent activity at the t…

1993-03-04 Dombivli, Maharashtra Strike Off Unlisted Active Compliant
Share
Connect MCP
GP Gabreal Pharmaceuticals Pvt Ltd
Open charges
0
0.00
Closed charges
2
4.75 Lakh
Total
2
4.75 Lakh
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Dombivli Nagari Sahakari Bank Ltd. 1 4.00 Lakh
2 Dombivli Nagrik Sahkari Bank Limited 1 75,000.00
All charges (2) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
10444365 Dombivli Nagari Sahakari Bank Ltd. 01 Aug 2013 01 Mar 2015 17 Mar 2023 4.00 Lakh Closed
90141768 Dombivli Nagrik Sahkari Bank Limited 16 Jul 1993 10 Dec 2003 17 Mar 2023 75,000.00 Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Gabreal Pharmaceuticals Pvt Ltd?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Gabreal Pharmaceuticals Pvt Ltd (CIN: U99999MH1993PTC071034). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Gabreal Pharmaceuticals Pvt Ltd.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.